Trial Profile
Phase 1 Multiple Ascending Dose Study of BMS-754807 in Patients With Solid Tumors in Japan.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Aug 2011
Price :
$35
*
At a glance
- Drugs BMS 754807 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 03 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Jul 2011 Planned end date changed from 1 Nov 2011 to 1 Jul 2011 as reported by ClinicalTrials.gov.
- 24 Jan 2011 Planned end date changed from 1 Feb 2012 to 1 Nov 2011 as reported by ClinicalTrials.gov.